The US Food and Drug Administration has taken steps to make it easier for patients with serious or immediately life-threatening illnesses to be treated under the agency's expanded access, or compassionate use, program1-3.
The program allows patients to be treated with experimental drugs in cases where there are no comparable alternatives.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?